Bi-anti therapy for sars-cov-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease

HIGHLIGHTS

• who: Jian Xu from the (UNIVERSITY) have published the research work: Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease, in the Journal: (JOURNAL)

SUMMARY

LETTER TO THE EDITOR Journal of Translational Medicine Open Access Bi‑anti therapy for SARS‑CoV‑2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease Jian Xu* department timely, the viral load of patients can be reduced as soon as possible to reduce the transmissibility, and more patients . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.